Gates Biomanufacturing Facility announces manufacture of recombinant protein – Alzheimer’s disease vaccine for Institute for Molecular Medicine’s clinical trials
The Gates Biomanufacturing Facility (GBF) has announced the successful completion of the full cycle manufacturing of the recombinant Bulk Drug ...